Thomas Pfisterer - 02 Jan 2024 Form 3 Insider Report for ADC Therapeutics SA (ADCT)

Role
Director, 10%+ Owner
Signature
/s/ Ameet Mallik, as Attorney-in-Fact for Thomas Pfisterer
Issuer symbol
ADCT
Transactions as of
02 Jan 2024
Net transactions value
$0
Form type
3
Filing time
02 Jan 2024, 20:00:16 UTC
Next filing
14 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ADCT Common Shares 175,337 02 Jan 2024 Direct F1
holding ADCT Common Shares 451,856 02 Jan 2024 By HPWH TH AG F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 20,000 Common Shares to be delivered in settlement of a restricted share unit award ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Shares. The RSUs were granted on June 14, 2023 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders, subject to the Reporting Person's continued service to the Issuer through the relevant vesting date.
F2 The reporting person disclaims beneficial ownership of all Common Shares held of record by HPWH TH AG ("HPWH"), other than the Common Shares in HPWH that are indirectly represented by the reporting person's 41.7% interest in HPWH MH AG, which owns a 12.5% interest in HPWH, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the remaining Common Shares in HPWH for purposes of Section 16 or for any other purpose.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney